Bone marrow stromal cells in patients with myelodysplastic syndrome (MDS) exhibit aging characteristics, and overexpression of S100A9 has been identified as an inducer of aging in low-risk MDS patients [116]. Here, S100A9 is linked to myelodysplastic syndrome.